Lupus News

WASHINGTON — At the American College of Rheumatology Annual Meeting, Robert M. Clancy, PhD, of the division of rheumatology at NYU Langone Medical Center, reviewed his study on lupus biomarkers located in non-sun-exposed and nonlesional skin of the buttocks.

WASHINGTON — At the American College of Rheumatology Annual Meeting, Amit Saxena, MD, assistant professor of medicine at the University of New York School of Medicine, reviewed his study on neonatal lupus and whether this can lead to autoimmune disease in later life.

WASHINGTON — At the American College of Rheumatology Annual Meeting, Ashira Blazer, MD, of the Division of Rheumatology at NYU School of Medicine, reviewed her study on the genetics of atherosclerosis in African-American patients with lupus.

Based on a cohort in Minnesota from 1985 through 2014, researchers found the yearly occurrence of mixed connective tissue disease to be two people per 100,000.

WASHINGTON — Concomitant class 5 lupus nephritis, along with a lower urine protein to creatinine ratio at baseline, were individually associated with complete renal response in patients with lupus, according to data presented at the American College of Rheumatology Annual Meeting.

WASHINGTON — Tubulointerstitial damage can predict end-stage renal disease progression in patients with lupus and mild to moderate renal impairment, according to data presented at the American College of Rheumatology Annual Meeting.

WASHINGTON — A large proportion of patients with lupus nephritis who were treated with a low dose of voclosporin met the primary endpoint of complete remission, according to results of the AURA study presented here at the American College of Rheumatology Annual Meeting.

Researchers presented data and clinical updates on lupus at the 2016 American College of Rheumatology Annual Meeting. Live coverage from Washington featured news from the conference, onsite video interviews with leading experts and research implications on patient care and practice.

WASHINGTON — Patients with lupus who were poor for more years showed more disease damage than patients who are poor for fewer years or were never poor, according to data presented at the American College of Rheumatology Annual Meeting, here.

WASHINGTON — Treatment of high homocysteine levels improved the urine protein/creatinine ratio in patients with lupus, according to data presented at the American College of Rheumatology Annual Meeting.